Table 3.
Specialty settings | n (%a) |
---|---|
Cancer | 45 (76) |
Prenatal | 7 (12) |
Cystic fibrosis | 2 (3) |
Down syndrome | 1 (2) |
Adult | 5 (9) |
Type 2 diabetes mellitus | 2 (3) |
Alzheimer’s disease | 2 (3) |
Pediatrics | 1 (2) |
Outcomes | n (%a) |
Psychological wellbeing [A] | 40 (69) |
Knowledge [B] | 29 (50) |
Perceived risk [C] | 23 (40) |
Satisfaction [D] | 20 (35) |
Intentions to pursue genetic testing / Screening [E] | 15 (26) |
Genetic testing uptake [F] | 11 (19) |
Decision quality [G] | 10 (17) |
Medical management / Health behavior [H] | 9 (16) |
Sharing information [I] | 5 (9) |
Informed choice [J] | 2 (5) |
These values correspond to the percentage of publications, and thus use 58 as the denominator